CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 166-180 of 739
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
CME/CELatest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Advanced Therapeutic Strategies and Resistance Mechanisms in CLL
CME/CEAdvanced Therapeutic Strategies and Resistance Mechanisms in CLL
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
CME/CEBreaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
CME/CEContinuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Identifying a Key Cause of Hard to Control Diabetes
CME/CEIdentifying a Key Cause of Hard to Control Diabetes
Chairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach
CME/CEChairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach
- advertisement
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
MinuteCE®Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
MinuteCE®Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Applications of Emerging Data in Resectable NSCLC
MinuteCE®Applications of Emerging Data in Resectable NSCLC
The Current Therapeutic Landscape in Unresectable Stage III NSCLC
MinuteCE®The Current Therapeutic Landscape in Unresectable Stage III NSCLC
- advertisement
Strategies in EGFR-mutated Unresectable Stage III NSCLC
MinuteCE®Strategies in EGFR-mutated Unresectable Stage III NSCLC
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
MinuteCE®Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC





























































